Midazolam Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Midazolam Hydrochloride Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 04/02/2020.
Shortage Details
- Status
- Current
- Company
- Hikma Pharmaceuticals USA, Inc.
- Package NDC
- 0641-6056-10
- Dosage Form
- Injection
- Presentation
- Midazolam Hydrochloride, Injection, 1 mg/1 mL (NDC 0641-6056-10)
- Initial Posting
- 04/02/2020
- Revised Date